Korean Drug Co Ltd
KOSDAQ:014570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tietoevry Oyj
OMXH:TIETO
|
FI |
Korean Drug Co Ltd
Tax Provision
Korean Drug Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Korean Drug Co Ltd
KOSDAQ:014570
|
Tax Provision
-₩1.3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-4%
|
|
|
Yuhan Corp
KRX:000100
|
Tax Provision
-₩37.4B
|
CAGR 3-Years
-105%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Tax Provision
₩102.4B
|
CAGR 3-Years
223%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Tax Provision
-₩26.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
6%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Tax Provision
-₩487.7m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
44%
|
CAGR 10-Years
17%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Tax Provision
-₩2.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Korean Drug Co Ltd
Glance View
KOREAN DRUG Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Icheon, Gyeonggi-Do and currently employs 256 full-time employees. The company went IPO on 2000-12-07. The Company’s products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.
See Also
What is Korean Drug Co Ltd's Tax Provision?
Tax Provision
-1.3B
KRW
Based on the financial report for Dec 31, 2025, Korean Drug Co Ltd's Tax Provision amounts to -1.3B KRW.
What is Korean Drug Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-4%
Over the last year, the Tax Provision growth was 36%. The average annual Tax Provision growth rates for Korean Drug Co Ltd have been 24% over the past three years , 7% over the past five years , and -4% over the past ten years .
